Advanced company searchLink opens in new window

ENVISION PHARMA FINCO LIMITED

Company number 10117627

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
24 Sep 2018 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/17
24 Sep 2018 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/17
24 Sep 2018 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/17
20 Jun 2018 SH20 Statement by Directors
20 Jun 2018 SH19 Statement of capital on 20 June 2018
  • USD 0.01
20 Jun 2018 CAP-SS Solvency Statement dated 20/06/18
20 Jun 2018 RESOLUTIONS Resolutions
  • RES13 ‐ Cancellation of share premium account 20/06/2018
  • RES06 ‐ Resolution of reduction in issued share capital
26 Apr 2018 CS01 Confirmation statement made on 10 April 2018 with no updates
10 Oct 2017 AA Audit exemption subsidiary accounts made up to 31 December 2016
10 Oct 2017 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/12/16
10 Oct 2017 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/12/16
10 Oct 2017 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/12/16
27 Apr 2017 AD03 Register(s) moved to registered inspection location Belmont House Station Way Crawley RH10 1JA
27 Apr 2017 AD02 Register inspection address has been changed to Belmont House Station Way Crawley RH10 1JA
24 Apr 2017 CS01 Confirmation statement made on 10 April 2017 with updates
02 Mar 2017 RESOLUTIONS Resolutions
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2017-02-02
06 Sep 2016 SH01 Statement of capital following an allotment of shares on 17 August 2016
  • USD 116,299,245.37
03 Aug 2016 SH01 Statement of capital following an allotment of shares on 6 July 2016
  • USD 116,299,244.37
20 Jul 2016 AP01 Appointment of Mr John David Gillie as a director on 6 July 2016
20 Jul 2016 AD01 Registered office address changed from 1 Grafton Street London W1S 4FE United Kingdom to Envision House 5 North Street Horsham West Sussex RH12 1XQ on 20 July 2016
06 Jun 2016 SH19 Statement of capital on 6 June 2016
  • USD 0.01
06 Jun 2016 SH20 Statement by Directors
06 Jun 2016 CAP-SS Solvency Statement dated 26/05/16
06 Jun 2016 SH14 Redenomination of shares. Statement of capital 26 May 2016
  • USD 0.014482
06 Jun 2016 RESOLUTIONS Resolutions
  • RES06 ‐ Resolution of reduction in issued share capital
  • RES 17 ‐ Resolution to redenominate shares